Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| 1 |
Stellantis
STLA
|
+$292M |
| 2 |
Constellation Brands
STZ
|
+$288M |
| 3 |
VMW
VMware, Inc
VMW
|
+$273M |
| 4 |
SPDR S&P Biotech ETF
XBI
|
+$261M |
| 5 |
NiSource
NI
|
+$240M |
Top Sells
| 1 |
Microsoft
MSFT
|
+$2.05B |
| 2 |
Apple
AAPL
|
+$1.81B |
| 3 |
UnitedHealth
UNH
|
+$1.01B |
| 4 |
Exxon Mobil
XOM
|
+$862M |
| 5 |
Tesla
TSLA
|
+$834M |
Sector Composition
| 1 | Technology | 27.58% |
| 2 | Consumer Discretionary | 11.38% |
| 3 | Healthcare | 10.81% |
| 4 | Financials | 10.71% |
| 5 | Communication Services | 6.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3351
Janux Therapeutics
JANX
$1.45B
| $108K | ﹤0.01% |
8,904
+4,296
| +93% | +$52.1K |
|
3352
KRONOS Worldwide
KRO
$694M
| $108K | ﹤0.01% |
11,666
+5,217
| +81% | +$48.3K |
|
3353
Nektar Therapeutics
NKTR
$926M
| $108K | ﹤0.01% |
10,184
-743
| -7% | -$7.88K |
|
3354
USCB Financial Holdings
USCB
$349M
| $108K | ﹤0.01% |
10,972
+2,602
| +31% | +$25.6K |
|
3355
Big 5 Sporting Goods
BGFV
$32.8M
| $107K | ﹤0.01% |
14,067
+5,128
| +57% | +$39K |
|
3356
Primis Financial Corp
FRST
$269M
| $107K | ﹤0.01% |
11,075
+5,125
| +86% | +$49.5K |
|
3357
MVB Financial
MVBF
$305M
| $107K | ﹤0.01% |
5,172
+2,422
| +88% | +$50.1K |
|
3358
Red River Bancshares
RRBI
$432M
| $106K | ﹤0.01% |
2,206
+1,034
| +88% | +$49.7K |
|
3359
Universal Logistics Holdings
ULH
$650M
| $106K | ﹤0.01% |
3,622
+1,693
| +88% | +$49.5K |
|
3360
Acumen Pharmaceuticals
ABOS
$80M
| $105K | ﹤0.01% |
25,952
-8,509
| -25% | -$34.4K |
|
3361
Adicet Bio
ACET
$67.5M
| $105K | ﹤0.01% |
18,338
-80,325
| -81% | -$460K |
|
|
AFCG
3362
AFC Gamma
AFCG
$105M
| $105K | ﹤0.01% |
12,643
+5,659
| +81% | +$47K |
|
3363
Alto Ingredients
ALTO
$91.3M
| $105K | ﹤0.01% |
70,377
-17,272
| -20% | -$25.8K |
|
|
GHIXW
3364
DELISTED
Gores Holdings IX, Inc. Warrant
GHIXW
| $105K | ﹤0.01% |
458,333
| – | – |
|
|
NETI
3365
DELISTED
Eneti Inc.
NETI
| $105K | ﹤0.01% |
11,196
+5,250
| +88% | +$49.2K |
|
3366
Rimini Street
RMNI
$417M
| $104K | ﹤0.01% |
25,082
+11,830
| +89% | +$49.1K |
|
|
AKTS
3367
DELISTED
AKOUSTIS TECHNOLOGIES, INC.
AKTS
| $104K | ﹤0.01% |
33,602
+19,309
| +135% | +$59.8K |
|
3368
CleanSpark
CLSK
$2.91B
| $103K | ﹤0.01% |
36,944
+24,691
| +202% | +$68.8K |
|
3369
Cambium Networks
CMBM
$20.4M
| $103K | ﹤0.01% |
5,797
+2,712
| +88% | +$48.2K |
|
3370
Lexicon Pharmaceuticals
LXRX
$418M
| $103K | ﹤0.01% |
42,296
+19,936
| +89% | +$48.5K |
|
3371
TransAlta
TAC
$3.75B
| $103K | ﹤0.01% |
11,800
+1,800
| +18% | +$15.7K |
|
3372
Workhorse Group
WKHS
$17.7M
| $103K | ﹤0.01% |
309
+145
| +88% | +$48.3K |
|
|
ROCL
3373
DELISTED
Roth CH Acquisition V Co. Common Stock
ROCL
| $103K | ﹤0.01% |
10,000
| – | – |
|
|
CONN
3374
DELISTED
Conn's Inc.
CONN
| $103K | ﹤0.01% |
17,107
+8,642
| +102% | +$52K |
|
|
HHLA.WS
3375
DELISTED
HH&L Acquisition Co. Redeemable warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50
HHLA.WS
| $103K | ﹤0.01% |
10,000
| – | – |
|